The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panic (Q35071487)

6 August 2017

1 reference

title

The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panic (English)

1 reference

6 August 2017

D Caroline Blanchard

1 reference

6 August 2017

Guy Griebel

series ordinal

1 reference

6 August 2017

Robert J Blanchard

series ordinal

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

European Journal of Pharmacology

6 August 2017

published in

1 reference

6 August 2017

volume

463

1 reference

6 August 2017

issue

1-3

1 reference

6 August 2017

page(s)

97-116

1 reference

Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Buspirone: future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Anxiogenic effects of a benzodiazepine receptor partial inverse agonist, RO 19-4603, in a light/dark choice situation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Flumazenil induces benzodiazepine partial agonist-like effects in BALB/c but not C57BL/6 mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Nonpeptide antagonists of neuropeptide receptors: tools for research and therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Antipredator defensive behaviors in a visible burrow system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

'Taming' of wild rats (Rattus rattus) by 5HT1A agonists buspirone and gepirone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Attenuation of defensive threat and attack in wild rats (Rattus rattus) by benzodiazepines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Diazepam changes risk assessment in an anxiety/defense test battery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

"Paradoxical" effects of morphine on antipredator defense reactions in wild and laboratory rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Evidence for differential effects of 8-OH-DPAT on male and female rats in the Anxiety/Defense Test Battery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Attenuation of antipredator defensive behavior in rats following chronic treatment with imipramine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Defense system psychopharmacology: an ethological approach to the pharmacology of fear and anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

An ethopharmacological analysis of selective activation of 5-HT1A receptors: the mouse 5-HT1A syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Differentiation of anxiolytic and panicolytic drugs by effects on rat and mouse defense test batteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Effect of CI-988 on cholecystokinin tetrapeptide-induced panic symptoms in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Acute intravenous administration of ondansetron and m-CPP, alone and in combination, in patients with obsessive-compulsive disorder (OCD): behavioral and biological results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Nociceptin/orphanin FQ receptor ligands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Pharmacology of nociceptin and its receptor: a novel therapeutic target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Anxiolytic-like profile of p-MPPI, a novel 5HT1A receptor antagonist, in the murine elevated plus-maze.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Influence of 5-HT1A receptor antagonism on plus-maze behaviour in mice. I. Pindolol enantiomers and pindobind 5-HT1A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Influence of 5-HT1A receptor antagonism on plus-maze behaviour in mice. II. WAY 100635, SDZ 216-525 and NAN-190.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Corticotrophin-releasing factor receptors: from molecular biology to drug design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Nociceptin/orphanin FQ inhibits stress- and CRF-induced anorexia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Absence of central effects in man of the benzodiazepine antagonist Ro 15-1788.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

5-HT and mechanisms of defence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Effect of predator exposure upon early pregnancy in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

The origin of the vasopressinergic and oxytocinergic innervation of the rat brain with special reference to the lateral septum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Molecular cloning, functional expression and chromosomal localization of the human cholecystokinin type A receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Changes in noradrenaline plasma levels and behavioural responses induced by benzodiazepine agonists with the benzodiazepine antagonist Ro 15-1788.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

7 January 2021

CCK receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Serotonergic mechanisms in anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Localization of neuropeptide receptor mRNA in rat brain: Initial observations using probes for neurotensin and substance P receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Some quantitative properties of anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Treatment of panic disorder with imipramine alone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Differential modulation of antipredator defensive behavior in Swiss-Webster mice following acute or chronic administration of imipramine and fluoxetine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Further evidence that the mouse defense test battery is useful for screening anxiolytic and panicolytic drugs: effects of acute and chronic treatment with alprazolam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

5-HT1A agonists modulate mouse antipredator defensive behavior differently from the 5-HT2A antagonist pirenperone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Evidence that the behaviors in the Mouse Defense Test Battery relate to different emotional states: a factor analytic study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Predator-elicited flight responses in Swiss-Webster mice: an experimental model of panic attacks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Preclinical profile of the mixed 5-HT1A/5-HT2A receptor antagonist S 21,357.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Behavioural profiles of the reversible monoamine-oxidase-A inhibitors befloxatone and moclobemide in an experimental model for screening anxiolytic and anti-panic drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

CCK receptor antagonists in animal models of anxiety: comparison between exploration tests, conflict procedures and a model based on defensive behaviours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Differences in anxiolytic-like profile of two novel nonbenzodiazepine BZ (omega) receptor agonists on defensive behaviors of mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Orphanin FQ, a novel neuropeptide with anti-stress-like activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Pharmacological studies on synthetic flavonoids: comparison with diazepam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Behavioural profiles in the mouse defence test battery suggest anxiolytic potential of 5-HT(1A) receptor antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

The effects of compounds varying in selectivity as 5-HT(1A) receptor antagonists in three rat models of anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Characterization of the profile of neurokinin-2 and neurotensin receptor antagonists in the mouse defense test battery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Effects of SR48968, a selective non-peptide NK2 receptor antagonist on emotional processes in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Neurotensin activates tuberoinfundibular dopamine neurons and increases serum corticosterone concentrations in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Novel anxiolytics that act as partial agonists at benzodiazepine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

The effect of stressor controllability on stress-induced neuropeptide mRNA expression within the paraventricular nucleus of the hypothalamus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Distribution of cholecystokinin-like immunoreactivity in the nervous system. Co-existence with classical neurotransmitters and other neuropeptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Comparison of buspirone and diazepam in generalized anxiety disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

OrphaninFQ: role in behavioral fear responses and vulnerability to stress?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Premedication by controlled-release morphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Immunocytochemical distribution of neurons containing a peptide derived from thyrotropin-releasing hormone precursor in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Cholecystokinin and anxiety in normal volunteers: an investigation of the anxiogenic properties of pentagastrin and reversal by the cholecystokinin receptor subtype B antagonist L-365,260

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Extrapituitary expression of the rat V1b vasopressin receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Molecular and neuronal substrate for the selective attenuation of anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Acute effects of low-dose flumazenil in panic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

The mammalian tachykinin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Ro 16-6028: a novel anxiolytic acting as a partial agonist at the benzodiazepine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

The effects of neurotensin on anterior pituitary hormone secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Inhibition of stress-induced neuroendocrine and behavioral responses in the rat by prepro-thyrotropin-releasing hormone 178-199.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Therapeutic effects of imipramine are counteracted by its metabolite, desipramine, in patients with generalized anxiety disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Two brain cholecystokinin receptors: implications for behavioral actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Molecular cloning and expression of a rat V1a arginine vasopressin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Effects of corticotropin-releasing factor (CRF), tuftsin and dermorphin on behavior of squirrel monkeys maintained by different events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Blockade of neurotensin binding in the rat hypothalamus and of the central action of neurotensin on the hypothalamic-pituitary-adrenal axis with non-peptide receptor antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Endogenous neurotensin regulates hypothalamic-pituitary-adrenal axis activity and peptidergic neurons in the rat hypothalamic paraventricular nucleus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Neural control of predatory aggression in wild and domesticated animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Neurotransmitter functions of mammalian tachykinins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Molecular cloning of the human brain and gastric cholecystokinin receptor: Structure, functional expression and chromosomal localization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Immunoregulators in the nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Serotonergic anxiolytics in the treatment of panic disorder: a controlled study with buspirone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Gepirone and diazepam in generalized anxiety disorder: a placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Distribution of neuropeptides in the limbic system of the rat: the amygdaloid complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Effects of scopolamine on antipredator defense reactions in wild and laboratory rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Stimulation of CRH-mediated ACTH secretion by central administration of neurotensin: evidence for the participation of the paraventricular nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Central administration of the neurotensin receptor antagonist, SR48692, modulates diurnal and stress-related hypothalamic-pituitary-adrenal activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Intrinsic activity of the benzodiazepine antagonist Ro 15-1788 in man: an electrophysiological investigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Ondansetron, gender and antipredator defensive behaviour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Tuftsin: on the 30-year anniversary of Victor Najjar's discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Fluoxetine in panic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Some properties of brain specific benzodiazepine receptors: New evidence for multiple receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Efficacy trial of the 5-HT2 antagonist MDL 11,939 in patients with generalized anxiety disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Behavioral, hormonal and histological stress markers of anxiety-separation in postnatal rats are reduced by prepro-thyrotropin-releasing hormone 178-199.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Vigilance and spatial cohesion among blue monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Effects of the 5-HT1A receptor agonist flesinoxan in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Tissue distribution and cellular localization of the levocabastine-sensitive neurotensin receptor mRNA in adult rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Developments in the drug treatment of panic disorder: what is the place of the selective serotonin reuptake inhibitors?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Current benzodiazepine issues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Behavioral, biochemical, and cardiovascular responses to the benzodiazepine receptor antagonist flumazenil in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Localization of vasopressin (V1a) receptor binding and mRNA in the rhesus monkey brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

Effects of hippocampal lesions on the rat's reaction to a cat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Antidepressant drugs in anxiety disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901276-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(03)01276-7

1 reference

6 August 2017

1 reference